Home Page



homePADPADD
disco4


news
companycontact linkssitemap


   h o m e  

Dialog Devices' main focus is on design, development and commercialisation of non-invasive biomedical health technology. The first application, Padd, is aimed at assessing peripheral arterial disease (PAD, reduced blood supply through legs) for preventing heart attacks and strokes.

Mission: We aspire to help meet the overwhelming demand for better healthcare through innovative optical technologies.

With the advances in opto-electronics we can now use natural light to ‘see’ below the surface of the skin non-invasively. This research has applications in all aspects of medical diagnosis and monitoring. Initially we are using this world-leading research to create products for use by healthcare workers, but in the long term we aim to introduce products for use by health-conscious consumers.
Jody Brown, Chief Executive



 

Padd in Action - video download

Winner: Lord Stafford Innovation in Development Awards 2008
Latest News

December 2008
Special commendation for Padd at Da Vinci Awards 2008.

November 2008
Padd Launched at Medica 2008.

November 2008
Padd presenting at Diabetes Technology Society Meeting.

October 2008
Padd Showcased at NHS Alliance Conference 2008.

September 2008
Lord Stafford Awards 2008 Winner!

August 2008
Rob Carson Joins Dialog Devices.

July 2008
Padd Patent awarded in Great Britain.

June 2008
Dialog Devices to present at In3 Medical Device Summit.

June 2008
Finalists in the 2008 Silicon Valley Boomer Business Plan Competition.

June 2008
Clinical studies for our second product begin at University Hospitals Leicester NHS Trust.

April 2008
The Department of Health awards grant to introduce Padd into primary care in the UK.

March 2008
Clinical studies for our second product begin at Leeds Teaching Hospitals NHS Trust.

February 2008
Aubrey Waddy joins Dialog Devices to provide clinical support.


more news...